Commentary: anthracyclines in early-stage breast cancer: is it the end of an era?
نویسنده
چکیده
Disclosures: Kathleen I. Pritchard: Consultant/advisory role: Novartis, Roche, AstraZeneca, GlaxoSmithKline, Amgen, Pfizer; Honoraria: GlaxoSmithKline, Amgen, Novartis, Roche, AstraZeneca, Pfizer; Expert testimony: AstraZeneca, Novartis, GlaxoSmithKline. The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias. No financial relationships relevant to the content of this article have been disclosed by the independent peer reviewers.
منابع مشابه
Anthracyclines in early-stage breast cancer: is it the end of an era?
Anthracycline regimens have been the mainstay of adjuvant care in breast cancer for >20 years. A growing body of clinical experience has uncovered an unacceptable rate of significant cardiac and leukomogenic toxicities. A systematic review of the literature was performed highlighting anthracycline- and nonanthracycline-based adjuvant regimens. The published data suggest that nonanthracycline al...
متن کاملThe Relationship between Breast Self-examination and the Disease Stage in Detection Time among Patients with Breast Cancer in Yazd
Introduction: breast cancer, as the most common cancer among women, is controllable if it is diagnosed at the early stages. Breast self- examination is a simple method for early detection. One of the most important effective factors on the cancer-related mortality is the defection stage. This study was conducted to determine the relationship between breast self-examination and the disease stage...
متن کاملYounger Patients, None-early Diagnostic Stage of Breast Cancer, and Low Breast Conservation Surgery, a Message in the Review of 102 Cases from South Iran
Background: Breast cancer is an important cause of cancer death among women all over the world. Even in places with low incidence there are reports of an increase in the number of breast cancer patients. The aim of the present study was to report the demographic aspects of breast cancer among patients referred by surgeons for adjuvant therapy in a private cancer clinic during the past five year...
متن کاملRapid Health Technology Assessment of Oncotype DX in Patients with Early-Stage Breast Cancer
Introduction: Breast cancer is the most common cancer in women. Patients are treated with chemotherapy initially, and if not chemically treated, the risk of recurrence of the disease increases yearly. Therefore, methods for identifying patients for whom chemotherapy would be most beneficial are very important. The Oncotype DX test is a prognostic assay that predicts the likelihood of breast can...
متن کاملDosimetric comparison of conventional and field-in-field techniques in early stage breast cancer radiotherapy
Introduction: Breast conserving surgery followed by adjuvant radiotherapy (RT) of the whole breast is accepted as the treatment of choice in early stage breast cancer. Due to breast irregularities, it is difficult to access homogenous dose distribution with conventional techniques. Currently, it is possible to use varied breast irradiation techniques, such as field- in-field (F...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The oncologist
دوره 14 10 شماره
صفحات -
تاریخ انتشار 2009